EUVIMEDEUVIMED entdecken
Crossref

Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein

Yezi Wu, Chuwei Yang, Xiafei Wei, Tongyang Xiao, Jian Zhou, Lujie Fan, Xiang Gao, Xiaotong Shen, Xiaomeng He, Gang Xu, Lei Liu, Yuzheng Zhou und 1 weitere

Journal of Medical Virology · 2025-12 · 97 (12)

DOI: 10.1002/jmv.70751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 17.12.2025. Verfasst von Yezi Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital,…. Hauptthemen laut MEDLINE: Albendazole, Ubiquitin-Protein Ligases, Ubiquitins, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key R&D Program of China, National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons constitute the host's primary antiviral defense system. It causes the expression of interferon‐stimulated genes (ISGs), including ISG15, which modulate viral replication. Here, we identify the E3 ligase HERC5—a crucial mediator of ISGylation—as an antiviral factor against SARS‐CoV‐2. Analysis using mass spectrometry showed that the viral nucleocapsid (N) protein is directly bound by HERC5, which then catalyzes ISGylation occurs at four lysine residues‐K61, K65, K102, and K355‐found in the NTD and CTD. Functional assays confirmed that ISGylation at these sites disrupts the N protein's capacity for RNA binding and oligomerization. Conversely, the papain‐like protease (PLpro) of SARS‐CoV‐2 cleaves ISG15 conjugates, thereby reversing N protein ISGylation. To discover small molecules that enhance the “HERC5‐N” interaction, we developed a NanoLuc luciferase‐based screening platform and evaluated 1815 FDA‐approved drugs. Albendazole emerged as a potent enhancer of “HERC5‐N” binding, further promoted N protein ISGylation, and inhibited viral replication. In vivo, Albendazole treatment reduced viral load and alleviated pulmonary inflammation in a transgenic mouse model of K18‐hACE2. Together, these findings reveal the crucial functionality of N protein ISGylation in SARS‐CoV‐2 replication and highlight HERC5‐mediated ISGylation as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleUbiquitin-Protein LigasesUbiquitinsCOVID-19 Drug TreatmentCoronavirus Nucleocapsid ProteinsCOVID-19Virus ReplicationHEK293 CellsIntracellular Signaling Peptides and ProteinsCytokinesSARS-CoV-2Antiviral AgentsCoronavirus Papain-Like ProteasesPhosphoproteinsProtein BindingViral LoadMice, TransgenicAngiotensin-Converting Enzyme 2Vero CellsChlorocebus aethiopsHumansAnimalsMiceDisease Models, Animal

Stichwörter der Autor:innen

HERC5ISGylationSARS‐CoV‐2albendazolenucleocapsid

Substanzen

AlbendazoleHERC5 protein, humanIntracellular Signaling Peptides and ProteinsUbiquitin-Protein LigasesISG15 protein, humanUbiquitinsCytokinesAntiviral Agentspapain-like protease, SARS-CoV-2Coronavirus Papain-Like Proteases

Autor:innen und Institutionen

  • Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…
  • Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China.
  • Department of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Zheng Zhang

Förderung

  • National Key R&D Program of China
  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • Major Project of Guangzhou National Laboratory
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Science and Technology Program

Zitieren

APA

Wu, Y., Yang, C., Wei, X., Xiao, T., Zhou, J., Fan, L., Gao, X., Shen, X., He, X., Xu, G., Liu, L., Zhou, Y., & Zhang, Z. (2025). Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein. Journal of Medical Virology, 97(12). https://doi.org/10.1002/jmv.70751

Vancouver

Wu Y, Yang C, Wei X, Xiao T, Zhou J, Fan L, et al. Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein. Journal of Medical Virology. 2025;97(12). doi:10.1002/jmv.70751

BibTeX
@article{Wu2025,
  author = {Wu, Yezi and Yang, Chuwei and Wei, Xiafei and Xiao, Tongyang and Zhou, Jian and Fan, Lujie and Gao, Xiang and Shen, Xiaotong and He, Xiaomeng and Xu, Gang and Liu, Lei and Zhou, Yuzheng and Zhang, Zheng},
  title = {Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {12},
  doi = {10.1002/jmv.70751}
}
Kostenlos starten →